R. Zwrtek

Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.

R. Greil, M. Gnant, H. Geinitz, 2020, European journal of cancer.

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected

M. Westerhoff, M. Gnant, A. Ba-Ssalamah, 2018, European Surgery.

TP53 Genotype but Not p53 Immunohistochemical Result Predicts Response to Preoperative Short-Term Radiotherapy in Rectal Cancer

R. Pötter, R. Jakesz, D. Kandioler, 2002, Annals of surgery.

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

A. Ba-Ssalamah, D. Kandioler, M. Mittlböck, 2014, The Journal of thoracic and cardiovascular surgery.

HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.

M. Gnant, P. Dubsky, R. Jakesz, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

HER 2 / neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer

M. Gnant, P. Dubsky, R. Jakesz, 2010 .

rt-PA Thrombolysis in Acute Thromboembolic Upper-Extremity Arterial Occlusion

E. Salomonowitz, M. Cejna, R. Zwrtek, 2001, CardioVascular and Interventional Radiology.

Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.

W. Klepetko, D. Kandioler, M. Mittlböck, 2008, The Journal of thoracic and cardiovascular surgery.